Latest News
SoFi Shares Slide Amid Muddy Waters Allegations, Mizuho Holds $38 Target
SoFi Technologies shares declined in premarket trading following a short-seller report from Muddy Waters alleging undisclosed debt. The company has refuted the claims and Mizuho Securities reiterated its $38 price target.
Plug Power's Turnaround Faces Wall Street Skepticism as New CEO Takes Charge
Plug Power's stock remains under pressure, trading around $2.29, as Wall Street awaits proof of new CEO Jose Luis Crespo's turnaround strategy. While the company reported 2025 revenue growth and a positive gross margin, liquidity concerns persist.
SCHD ETF Gains Investor Attention Following Annual Rebalance and Dividend Payout
The Schwab U.S. Dividend Equity ETF (SCHD) is drawing renewed interest following its annual portfolio rebalance and a recent dividend distribution. The fund's strategic shift and income profile are being highlighted as key attractions for investors.
Hyatt Accelerates AI Rollout to Boost Direct Bookings, Amex Offer Targets Loyalty
Hyatt is rapidly deploying AI search and management tools across its portfolio, aiming to capture travelers earlier in the planning process and increase direct bookings. The company is also offering select American Express cardholders a $75 incentive for direct bookings.
SMCI Rebounds Premarket Amid Analyst Downgrades, Export Probe Fallout
Super Micro Computer stock climbed 2.7% in premarket trading Wednesday, recovering from last week's sharp drop. Analysts downgraded the stock, citing risks from an ongoing export-control investigation.
Grab Announces $400M Buyback and Taiwan Expansion, Shares Rally
Grab Holdings saw its stock climb over 4% following the announcement of a $400 million share buyback program and a strategic $600 million acquisition of foodpanda's Taiwan operations, its first expansion outside Southeast Asia.
Ondas Shares Dip Amid Ambitious Growth Targets and World View Acquisition
Ondas Holdings shares fell in premarket trading following its 2025 earnings, which revealed a deeper net loss of $133.4 million, a major acquisition, and a significantly raised revenue target for the coming year.
ImmunityBio Plunges 21% on FDA Warning Over Anktiva Marketing
ImmunityBio shares tumbled 21.1% following an FDA warning letter alleging false or misleading promotional claims about its cancer therapy Anktiva. The drug generated essentially all of the company's $113 million in 2025 revenue.
Intel Shares Surge on AI Server Demand, Arm Chip Launch
Intel shares climbed 3.8% ahead of Wednesday's opening bell, buoyed by Arm's launch of a new AI data-center processor and renewed focus on server CPU demand. The chipmaker's market valuation reached approximately $155.4 billion.
B2Gold Shares Recover Amid Gold Slump, But 2026 Cost Hurdles Emerge
B2Gold's U.S. shares rose 1% to $4.12, continuing a rebound, but remain down nearly 15% from last week. The company forecasts increased costs and lower output for 2026.